Skip to main content

Efficacy and Safety of Therapeutics in Immuno-modulatory Induced Cytokine Release Syndrome

Brian W. Soper, Ph.D. speaks about the efficacy and safety of therapeutics in immuno-modulatory induced cytokine release syndrome. Dr. Soper discusses human PBMC engraftment profiles; modeling human cytokine release syndrome in vivo; and preclinical tumor efficacy with mAb’s, bispecifics, and CAR T.